Q1 2025 Management View CEO Art Penn highlighted that GAAP and core net investment income for the quarter was $0.20 per share, which fell short of the quarterly dividend by $0.04. He emphasized the ...
We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...